Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
2O IMpower010: Biomarkers of disease-free survival (DFS) in a phase III study of atezolizumab (atezo) vs best supportive care (BSC) after adjuvant chemotherapy in stage IB-IIIA NSCLC
PaperCitations, authors & open-access status
2O IMpower010: Biomarkers of disease-free survival (DFS) in a phase III study of atezolizumab (atezo) vs best supportive care (BSC) after adjuvant chemotherapy in stage IB-IIIA NSCLC is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 76 citations, 2021 year and closed oa status.
76
Citations
2021
Year
closed
OA Status